academic article

• Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma..  Journal of immunotherapy (Hagerstown, Md. : 1997).  31:72-80. 2008